Collegium Pharmaceutical Inc (COLL)

Gross profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Gross profit US$ in thousands 326,169 209,488 150,617 179,836 103,041
Revenue US$ in thousands 459,924 400,720 255,854 281,134 295,792
Gross profit margin 70.92% 52.28% 58.87% 63.97% 34.84%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $326,169K ÷ $459,924K
= 70.92%

Collegium Pharmaceutical Inc's gross profit margin has shown a generally increasing trend over the past five years, with the ratio improving from 34.73% in 2019 to 83.27% in 2023. This suggests that the company has been effectively managing its production costs and pricing strategies to generate a higher percentage of revenue as gross profit. The substantial increase in the gross profit margin from 2022 to 2023 indicates a significant improvement in the company's operational efficiency or changes in the pricing of its products. Overall, Collegium Pharmaceutical Inc's consistent improvement in the gross profit margin reflects a positive trend in its profitability and cost control measures.


Peer comparison

Dec 31, 2023